瑞典西部30年间原发性醛固酮增多症发病率上升但仍诊断不足
该研究基于瑞典国家患者登记数据,评估1987至2016年西约塔兰县原发性醛固酮增多症(PA)的发病率与患病率。共确认416例PA患者,年发病率从1987-1996年的中位2例/百万升至2007-2016年的17例/百万,但2016年底患病率仅231例/百万(0.022%),仍低于预期,提示诊断不足。
要点
- 研究结束时患病率仅0.022%,远低于预期,提示大量患者未被诊断。
- 应提高医疗提供者对PA的认知,以避免未治疗PA的严重后果。
核心结论
- 尽管PA发病率上升,但识别出的患者比例仍低于预期,患病率低提示诊断不足。
- 鉴于未治疗PA的严重后果,需提高医疗提供者对PA的认知。
研究设计与样本
- 基于瑞典国家患者登记数据,识别1987至2016年间获得PA诊断编码的患者。
- 通过临床和生化数据评估验证诊断,并以西约塔兰县居民数为参考计算年发病率。
- 共570例识别患者中473例(83%)确诊PA,其中416例纳入发病率分析。
主要发现
- 纳入发病率分析的416例中,男性248例(60%),女性168例(40%)。
- 诊断时平均年龄为56±12岁。
- 年发病率中位数(四分位距):1987-1996年为2(1-2)例/百万,1997-2006年为6(4-9)例/百万,2007-2016年为17(12-24)例/百万。
- 2016年12月31日,386例确诊PA患者存活并居住于西约塔兰县,患病率为231例/百万(0.022%)。
临床怎么用
- 临床医生应提高对PA的筛查意识,尤其在高血压患者中考虑PA可能。
- 鉴于PA发病率上升但仍诊断不足,应加强对PA的识别和诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Primary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the general population has not been studied. OBJECTIVE: To estimate the incidence of PA in the general population. DESIGN AND METHODS: Patients who had received a diagnostic code for PA between 1987 and 2016 were identified in the Swedish National Patient Registry. Assessment of clinical and biochemical data was used to validate the diagnosis. The annual incidence of PA was calculated by using the number of inhabitants in the Västra Götaland County as a reference. RESULTS: Of 570 identified patients, 473 (83%) had confirmed PA. Eligible for the incidence analysis were 416 patients, 248 (60%) men and 168 (40%) women, diagnosed with PA between 1987 and 2016. The mean (± standard deviation) age at diagnosis was 56 ± 12 years. The median (interquartile range) annual incidence was 2 (1-2) cases per million between 1987 and 1996, 6 (4-9) cases per million between 1997 and 2006 and 17 (12-24) cases per million between 2007 and 2016. At the end of the study (December 31, 2016), 386 patients with confirmed PA were alive and living in the Västra Götaland County, giving a prevalence of 231 cases per million (0.022%). CONCLUSIONS: Despite increasing incidence, the proportion of patients identified with PA is lower than expected. Given the serious consequences of untreated PA, the noticeably low prevalence at the end of the study stresses the need to increase the awareness of PA among health care providers.
引用
- Gkaniatsa E, Ekerstad E, Gavric M, et al. Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder. J Clin Endocrinol Metab. 2021. PMID: 33974052. doi:10.1210/clinem/dgab327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。